Traumatic Brain Injury Feasibility Study (EPIC-011)

Study Overview
=================
Brief Summary
-----------------
The purpose of this research study is to evaluate whether data made by the ClearView System can be used to detect whether someone has a traumatic brain injury and how severe the injury is.

Detailed Description
-----------------
Traumatic brain injury (TBI) is a significant cause of death and disability in the U.S. The severity of a TBI may range from mild (i.e. a brief change in mental status or consciousness) to severe (i.e. an extended period of unconsciousness or memory loss after the injury). However, most TBI's that occur each year are mild and are commonly called concussions. Unfortunately, TBI terminology does not adequately describe the injury or impairment, its treatment, or the resulting outcomes. Due to the complexity of the human brain, each person's physiology can result in different patterns of impairment and secondary conditions, requiring different treatment or rehabilitation. The intent of EPIC ClearView™ TBI Feasibility (EPIC-011) is to collect data to further develop the ClearView™ Response Scale to measure electrophysiology associated with TBI

Official Title
-----------------
Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™

Conditions
-----------------
Traumatic Brain Injury, Controls

Intervention / Treatment
-----------------
* Device: ClearView Scanning


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Suspected TBI population: Acute head trauma within 24-72 hours of presentation 18-65 age inclusive GCS of 3-15 on initial evaluation in ED Control population: 18-65 age inclusive GCS score of 15 Exclusion Criteria: Current neurological disease Current severe psychological disorder History of substance or alcohol abuse Under drug or alcohol influence, if so, must wait at least 24 hrs. prior to consent Documented current diagnosis/treatment of cancer (including Sickle Cell Disease) Current treatment to the head/brain (radiation, whole brain therapy, gamma knife) Head injury in the last two years Unwilling to sign informed consent Pregnant or potentially pregnant Pacemaker, automatic implanted cardiac defibrillator or other implanted electrical device Connected to an electronic device that cannot be removed Missing all or part of fingers or cuts/burns on pads of fingers Long fingernails and unwilling to cut them and keep them cut for the duration of the study Hand tremors or involuntary oscillations (shaking) of the hands that prevents clear imaging Additional exclusion criteria for control population: Previous head trauma

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Traumatic Brain Injury<br>Men and women ages 18-65 with suspected acute head trauma within 24-72hrs. of presentation, scoring a 3-15 on initial evaluation on GCS scale. | |
| Control<br>Men and women ages 18-65 with no history of head trauma and a score of 15 on the GCS scale. | Device: ClearView Scanning<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Agreement of ClearView Scan versus Active Diagnosis | The EPIC ClearView software produces a Response Scale report that summaries the electrophysiological measurements associated with organ systems. The autonomic numbers indicate how the person's stress response is affecting different body systems and the physical numbers reflect physiological function. These measurements will then be compared to TBI diagnosis, based on one or two possible scans | I day unless TBI population chooses to participate in one week follow up | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Comparison of TBI subjects to Controls | Will measure comparisons of data from one visit | 1 day unless TBI population chooses to participate in one week follow up | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Controls